102 related articles for article (PubMed ID: 18202799)
21. Aurora kinase B is a predictive factor for the aggressive recurrence of hepatocellular carcinoma after curative hepatectomy.
Tanaka S; Arii S; Yasen M; Mogushi K; Su NT; Zhao C; Imoto I; Eishi Y; Inazawa J; Miki Y; Tanaka H
Br J Surg; 2008 May; 95(5):611-9. PubMed ID: 18311747
[TBL] [Abstract][Full Text] [Related]
22. Wnt-1 protein as a prognostic biomarker for hepatitis B-related and hepatitis C-related hepatocellular carcinoma after surgery.
Lee HH; Uen YH; Tian YF; Sun CS; Sheu MJ; Kuo HT; Koay LB; Lin CY; Tzeng CC; Cheng CJ; Tang LY; Tsai SL; Wang AH
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1562-9. PubMed ID: 19423534
[TBL] [Abstract][Full Text] [Related]
23. Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection.
Yang XR; Xu Y; Shi GM; Fan J; Zhou J; Ji Y; Sun HC; Qiu SJ; Yu B; Gao Q; He YZ; Qin WZ; Chen RX; Yang GH; Wu B; Lu Q; Wu ZQ; Tang ZY
Clin Cancer Res; 2008 Jun; 14(12):3850-9. PubMed ID: 18559605
[TBL] [Abstract][Full Text] [Related]
24. Surgical contribution to recurrence-free survival in patients with macrovascular-invasion-negative hepatocellular carcinoma.
Tanaka S; Mogushi K; Yasen M; Noguchi N; Kudo A; Kurokawa T; Nakamura N; Inazawa J; Tanaka H; Arii S
J Am Coll Surg; 2009 Mar; 208(3):368-74. PubMed ID: 19317998
[TBL] [Abstract][Full Text] [Related]
25. Albumin mRNA in plasma predicts post-transplant recurrence of patients with hepatocellular carcinoma.
Cheung ST; Fan ST; Lee YT; Chow JP; Ng IO; Fong DY; Lo CM
Transplantation; 2008 Jan; 85(1):81-7. PubMed ID: 18192916
[TBL] [Abstract][Full Text] [Related]
26. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
Yamamoto K; Imamura H; Matsuyama Y; Hasegawa K; Beck Y; Sugawara Y; Makuuchi M; Kokudo N
Ann Surg Oncol; 2009 Oct; 16(10):2795-804. PubMed ID: 19669841
[TBL] [Abstract][Full Text] [Related]
27. Detection of MAGE-1, MAGE-3 and AFP mRNA as multimarker by real-time quantitative PCR assay: a possible predictor of hematogenous micrometastasis of hepatocellular carcinoma.
Zhang Y; Li Q; Liu N; Song T; Liu Z; Guo R; Meng L
Hepatogastroenterology; 2008; 55(88):2200-6. PubMed ID: 19260505
[TBL] [Abstract][Full Text] [Related]
28. Deregulated expression of microRNA-221 with the potential for prognostic biomarkers in surgically resected hepatocellular carcinoma.
Yoon SO; Chun SM; Han EH; Choi J; Jang SJ; Koh SA; Hwang S; Yu E
Hum Pathol; 2011 Oct; 42(10):1391-400. PubMed ID: 21458843
[TBL] [Abstract][Full Text] [Related]
29. High serum levels of vascular endothelial growth factor after hepatectomy are associated with poor prognosis in hepatocellular carcinoma.
Tamesa T; Iizuka N; Mori N; Okada T; Takemoto N; Tangoku A; Oka M
Hepatogastroenterology; 2009; 56(93):1122-6. PubMed ID: 19760954
[TBL] [Abstract][Full Text] [Related]
30. Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection.
Iizuka N; Oka M; Yamada-Okabe H; Nishida M; Maeda Y; Mori N; Takao T; Tamesa T; Tangoku A; Tabuchi H; Hamada K; Nakayama H; Ishitsuka H; Miyamoto T; Hirabayashi A; Uchimura S; Hamamoto Y
Lancet; 2003 Mar; 361(9361):923-9. PubMed ID: 12648972
[TBL] [Abstract][Full Text] [Related]
31. Decreased expression of inhibitor of growth 4 correlated with poor prognosis of hepatocellular carcinoma.
Fang F; Luo LB; Tao YM; Wu F; Yang LY
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):409-16. PubMed ID: 19208663
[TBL] [Abstract][Full Text] [Related]
32. Correlations of the expression of vascular endothelial growth factor B and its isoforms in hepatocellular carcinoma with clinico-pathological parameters.
Kanda M; Nomoto S; Nishikawa Y; Sugimoto H; Kanazumi N; Takeda S; Nakao A
J Surg Oncol; 2008 Sep; 98(3):190-6. PubMed ID: 18537151
[TBL] [Abstract][Full Text] [Related]
33. Aberrant expression of the glycolytic enzymes aldolase B and type II hexokinase in hepatocellular carcinoma are predictive markers for advanced stage, early recurrence and poor prognosis.
Peng SY; Lai PL; Pan HW; Hsiao LP; Hsu HC
Oncol Rep; 2008 Apr; 19(4):1045-53. PubMed ID: 18357395
[TBL] [Abstract][Full Text] [Related]
34. Oxidative stress pathways in noncancerous human liver tissue to predict hepatocellular carcinoma recurrence: a prospective, multicenter study.
Tanaka S; Mogushi K; Yasen M; Ban D; Noguchi N; Irie T; Kudo A; Nakamura N; Tanaka H; Yamamoto M; Kokudo N; Takayama T; Kawasaki S; Sakamoto M; Arii S
Hepatology; 2011 Oct; 54(4):1273-81. PubMed ID: 22006857
[TBL] [Abstract][Full Text] [Related]
35. Identifying risk for recurrent hepatocellular carcinoma after liver transplantation: implications for surveillance studies and new adjuvant therapies.
Chan EY; Larson AM; Fix OK; Yeh MM; Levy AE; Bakthavatsalam R; Halldorson JB; Reyes JD; Perkins JD
Liver Transpl; 2008 Jul; 14(7):956-65. PubMed ID: 18581511
[TBL] [Abstract][Full Text] [Related]
36. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.
Yang XR; Xu Y; Yu B; Zhou J; Li JC; Qiu SJ; Shi YH; Wang XY; Dai Z; Shi GM; Wu B; Wu LM; Yang GH; Zhang BH; Qin WX; Fan J
Clin Cancer Res; 2009 Sep; 15(17):5518-27. PubMed ID: 19706825
[TBL] [Abstract][Full Text] [Related]
37. Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: a retrospective study.
Kawano Y; Sasaki A; Kai S; Endo Y; Iwaki K; Uchida H; Shibata K; Ohta M; Kitano S
Eur J Surg Oncol; 2009 Feb; 35(2):174-9. PubMed ID: 18325724
[TBL] [Abstract][Full Text] [Related]
38. Identification of PEG10 as a progression related biomarker for hepatocellular carcinoma.
Ip WK; Lai PB; Wong NL; Sy SM; Beheshti B; Squire JA; Wong N
Cancer Lett; 2007 Jun; 250(2):284-91. PubMed ID: 17126992
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC.
Toyoda H; Kumada T; Kaneoka Y; Osaki Y; Kimura T; Arimoto A; Oka H; Yamazaki O; Manabe T; Urano F; Chung H; Kudo M; Matsunaga T
J Hepatol; 2008 Aug; 49(2):223-32. PubMed ID: 18571271
[TBL] [Abstract][Full Text] [Related]
40. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma.
Katz SC; Shia J; Liau KH; Gonen M; Ruo L; Jarnagin WR; Fong Y; D'Angelica MI; Blumgart LH; Dematteo RP
Ann Surg; 2009 Apr; 249(4):617-23. PubMed ID: 19300227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
